Bioavailability Study
5 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Relative Bioavailability of Early Phase and Late Phase Hetrombopag Olamine Formulations (NCT04688008) | Jiangsu HengRui Medicine Co., Ltd. | 2020-09-18 |
| NPC-12G Gel 0.2% Sirolimus PK Bridging Study (NCT03972462) | Nobelpharma | 2019-05-31 |
| A Study to Compare the PK, PD and Safety and Tolerability of a SC With an IV Formulation of ARGX-113 in Healthy Male Subjects (NCT03334084) | argenx | 2017-10-11 |
| Study to Analyse Difference in Bioavailability Between MP29-02 and Fluticasone Propionate (NCT02883439) | University Hospital, Ghent | 2016-08-01 |
Track Bioavailability Study automatically
Every clearance here is in the API, with alerts when new ones post.